StreetInsider.com News Articles

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Pauls Matthew

Tue, 07 Jul 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260707/26742582.html

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Pauls Matthew

Tue, 07 Jul 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260707/26742582.html

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Friedberg Ezra M

Tue, 07 Jul 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260707/26742586.html

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Friedberg Ezra M

Tue, 07 Jul 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260707/26742586.html

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Greenleaf Peter

Tue, 07 Jul 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260707/26742578.html

Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Greenleaf Peter

Tue, 07 Jul 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260707/26742578.html

Pelthos Therapeutics added to Russell Microcap indexes

Tue, 30 Jun 2026 16:15:26 -0400

Pelthos Therapeutics Inc. (NYSE American: PTHS) was added to the Russell 3000E™ Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes, effective when the U.S. market opened June 29, as part of the 2026 Russell indexes reconstitution, according to a company statement.

The annual Russell US Indexes reconstitution ranks up to the 4,000 largest U.S. stocks by total market capitalization, using data as of April 30. Beginning in 2026, the Russell US Indexes are reconstituted on a semi-annual basis in June and December. Membership in the Russell Microcap® Index also results in automatic inclusion in the appropriate growth and value

Pelthos Therapeutics added to Russell Microcap indexes

Tue, 30 Jun 2026 16:15:26 -0400

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Tue, 30 Jun 2026 16:15:00 -0400

DURHAM, N.C., June 30, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos”), today announced that the company was added as a member of the Russell 3000E™ Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes effective when the US market opened on June 29 as part of the 2026 Russell indexes reconstitution.

The June Russell US Indexes reconstitution captures up to the 4,000 largest US stocks as of Thursday, April 30th, ranking them by total market capitalization. Beginning

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Tue, 30 Jun 2026 16:15:00 -0400

The June Russell US Indexes reconstitution captures up to the 4,000 largest US stocks as of Thursday, April 30th, ranking them by total market capitalization. Beginning

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Tue, 30 Jun 2026 16:15:00 -0400

The June Russell US Indexes reconstitution captures up to the 4,000 largest US stocks as of Thursday, April 30th, ranking them by total market capitalization. Beginning

Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes

Tue, 30 Jun 2026 16:15:00 -0400

The June Russell US Indexes reconstitution captures up to the 4,000 largest US stocks as of Thursday, April 30th, ranking them by total market capitalization. Beginning

Form 4 Pelthos Therapeutics For: Jun 15 Filed by: Friedberg Ezra M

Wed, 17 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260617/26661005.html

Form 4 Pelthos Therapeutics For: Jun 15 Filed by: Friedberg Ezra M

Wed, 17 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260617/26661005.html

Form 4 Pelthos Therapeutics For: Jun 11 Filed by: Davis Todd C

Mon, 15 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260615/26648701.html

Form 4 Pelthos Therapeutics For: Jun 11 Filed by: Davis Todd C

Mon, 15 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260615/26648701.html

Form 8-K Pelthos Therapeutics For: May 28

Thu, 28 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260528/26568705.html

Form 8-K Pelthos Therapeutics For: May 28

Thu, 28 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260528/26568705.html

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

DURHAM, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos”), today announced that CEO Scott Plesha will present at 11:05 am ET and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference on June 4, 2026 in New York. Investors interested in arranging one-on-one meetings should contact their Jefferies representative.

About Pelthos Therapeutics